Nautilus Biotechnology, Inc. (NAUT)

2.04 0.00 (0.00%) USD  |  NASDAQ  |  Dec 10, 10:17
More

Nautilus Biotechnology EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for NAUT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Prelude Therapeutics, Inc. Upgrade
Protalix Biotherapeutics, Inc. Upgrade
Genprex, Inc. Upgrade
GoodRx Holdings, Inc. Upgrade
Pelthos Therapeutics, Inc. --